United States · FDA National Drug Code directory
ARISTADA INITIO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65757-500_cbde23b9-60d1-4ae1-b42d-1093610ba18d
- Product NDC
- 65757-500
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- aripiprazole lauroxil
- Labeler
- Alkermes, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180629
- Source listing expiry
- 20261231
Source-listed ingredients
- ARIPIPRAZOLE LAUROXIL — 675 mg/2.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (65757-500-03) / 2.4 mL in 1 SYRINGE · 65757-500-03
- 1 SYRINGE in 1 CARTON (65757-500-04) / 2.4 mL in 1 SYRINGE · 65757-500-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →